노인 만성폐쇄성폐질환
Chronic obstructive pulmonary disease in the older patient
0
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and health care problems in older patients. Recently, our country became an ageing society and the prevalence of COPD in older patients will be increasing continuously. The diagnosis of COPD is confirmed by spirometry. An obstructive defect is defined as a reduced post expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio. Using the fixed FEV1/FVC ratio may create a risk for under diagnosis in young patients and overdiagnosis in older patients. The FEV1/FVC ratio decreases with age and clear consensus definition of diagnostic criteria for COPD in older patients is needed. Older patients who have COPD benefit from all effective therapies available to treat COPD. Older patients have more comorbidities that influence quality of life, prognosis and medical management. Attention for comorbidities improves the lives of older patients who have COPD. (Korean J Med 75:149-152, 2008)
Abstract
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and health care problems in older patients. Recently, our country became an ageing society and the prevalence of COPD in older patients will be increasing continuously. The diagnosis of COPD is confirmed by spirometry. An obstructive defect is defined as a reduced post expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio. Using the fixed FEV1/FVC ratio may create a risk for under diagnosis in young patients and overdiagnosis in older patients. The FEV1/FVC ratio decreases with age and clear consensus definition of diagnostic criteria for COPD in older patients is needed. Older patients who have COPD benefit from all effective therapies available to treat COPD. Older patients have more comorbidities that influence quality of life, prognosis and medical management. Attention for comorbidities improves the lives of older patients who have COPD. (Korean J Med 75:149-152, 2008)
참고문헌 (20)
- Mannino DM, "COPD: epidemiology, prevalence, morbidity and mortality heterogeneity", Chest, 121(5), pp.11~16 (2002)
- DS Kim, "Prevalence of Chronic Obstructive Pulmonary Disease in Korea", Am J Respir Crit Care Med, 172, pp.842~847 (2005)
- Pellegrino R, "Interpretative strategies for lung function tests", Eur Respir J, 26, pp.948~968 (2005)
- "Lung function testing: selection of reference values and interpretative strategies", Am Rev Respir Dis, 477, pp.1202~1218, American Thoracic Society
- Celli BR, "Population impact of different definitions of airway obstruction", Eur Respir J, 22, pp.268~273 (2003)
- Hardie JA, "Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers", Eur Respir J, 20, pp.1117~1122 (2002)
- Medbø A, "Lung function testing in the elderly-can we still use FEV1", FVC<70% as a criterion of COPD?, 2007, pp.101, 1097~1105
- Hansen JE, "Spirometric criteria for airway obstruction: Use percentage of FEV1", FVC ratio below the fifth percentile, not < 70%, 2007, pp.131, 349~355
- Mannino DM, "Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?", Thorax, 62, pp.237~241 (2007)
- Lindberg A, "Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies", Respir Med, 100, pp.264~272 (2006)
- Taylor DH Jr, "Benefits of smoking cessation for longevity", Am J Public Health, 92, pp.990~996 (2002)
- Maguire CP, "Do patient age and medical condition influence medical advice to stop smoking?", Age Ageing, 29, pp.264~266 (2000)
- Lung Health Study Research Group, "Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease", N Engl J Med, 343, pp.1902~1909 (2000)
- Calverley PM, "TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease", N Engl J Med, 356, pp.775~789 (2007)
- Couser JI Jr, "Pulmonary rehabilitation improves exercise capacity in older elderly patients with COPD", Chest, 107, pp.730~734 (1995)
- Wilson D, "ffin R and on behalf of the North West Adelaide (Cohort) Study Team. Difficulties Identifying and Targeting COPD and Population-Attributable Risk of Smoking for COPD: A Population Study", Chest, 128, pp.2035~2042 (2005)
- Light RW, "Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity", Chest, 87, pp.35~38 (1985)
- Yohannes AM, "Depression in elderly outpatients with disabling chronic obstructive pulmonary disease", Age Ageing, 27, pp.155~160 (1998)
- Antonelli Incalzi R, "Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease", Eur Respir J, 10, pp.2794~2800 (1997)
- Anthonisen NR, "Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial", Ann Intern Med, 142, pp.233~239 (2005)